Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | APEX1 | P27695 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17499019 | 0.92 | THRB (0.48) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL19772746 | 0.91 | THRB (0.52) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL16441931 | 0.90 | THRB (0.50) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL13400212 | 0.89 | TSHR (0.48) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL29144863 | 0.87 | TSHR (0.46) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL212008 | 0.86 | THRB (0.55) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL670913 | 0.84 | THRB (0.53) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL673043 | 0.84 | THRB (0.53) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL671674 | 0.84 | THRB (0.53) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL599919 | 0.84 | THRB (0.53) | THRBTSHRALDH1A1TDP1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2575 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122011975-A | Force-sensitive self-reinforced adhesive for silicon-based negative electrode of lithium ion battery, and preparation method and application thereof | 湖南智电谷能源科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122028909-A | Lipid nanoparticles with non-covalent bifunctional conjugates for active targeting | 莫特治疗股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| WO-2026090590-A1 | NANOPARTICLE FORMULATIONS FOR THE DELIVERY OF DNA TO ADIPOSE TISSUE | Remedium Bio, Inc. (US) | 2026-04-30 | — | — | WO | claimed |
| US-12570887-B2 | Ultra-high molecular weight (UHMW) branched block copolymer viscosifier for water based drilling fluids | SAUDI ARABIAN OIL COMPANY (SA) | 2026-03-10 | — | — | US | claimed |
| WO-2026042014-A1 | A PHOTOCURABLE ACRYLATE RESIN MONOMER AND THE USE THEREOF | LEVOBIO LIMITED (CN) | 2026-02-26 | — | — | WO | claimed |
| EP-4687990-A1 | METHOD OF SYNTHESIS OF TARGETED LIPID NANOPARTICLE AND USES THEREOF | OSE IMMUNOTHERAPEUTICS (FR) | 2026-02-11 | — | — | EP | claimed |
| EP-4688891-A2 | COMPOSITIONS AND METHODS FOR MAKING A REVERSIBILY-CROSSLINKED POLYMER | Braskem America, Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| EP-4687992-A1 | LIPID-BASED NANOPARTICLE TARGETED AT ACTIVATED IMMUNE CELLS FOR THE EXPRESSION OF IMMUNE CELL INHIBITING MOLECULE AND USE THEREOF | OSE IMMUNOTHERAPEUTICS (FR) | 2026-02-11 | — | — | EP | claimed |
| EP-4687991-A1 | LIPID-BASED NANOPARTICLE TARGETED AT ACTIVATED IMMUNE CELLS FOR THE EXPRESSION OF IMMUNE CELL ENHANCING MOLECULE AND USE THEREOF | OSE IMMUNOTHERAPEUTICS (FR) | 2026-02-11 | — | — | EP | claimed |
| US-12509583-B2 | Particle surface modification to increase compatibility and stability in hydrogels | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2025-12-30 | — | — | US | claimed |
| EP-2906242-A1 | DELIVERY OF SMALL INTERFERING RNA AND MICRO RNA THROUGH MEMBRANE-DISRUPTIVE, RESPONSIVE NANOSCALLE HYDROGELS | Board Of Regents, The University Of Texas System (US) | 2015-08-19 | — | — | EP | claimed |
| US-20150216814-A1 | DELIVERY OF SMALL INTERFERING RNA AND MICRO RNA THROUGH MEMBRANE-DISRUPTIVE, RESPONSIVE NANOSCALLE HYDROGELS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2015-08-06 | — | — | US | claimed |
| WO-2015077771-A1 | ORDERED MACROPOROUS HYDROGELS FOR BIORESPONSIVE PROCESSES | CARNEGIE MELLON UNIVERSITY (US) | 2015-05-28 | — | — | WO | claimed |
| WO-2015020625-A1 | GEL ELECTROLYTE COMPOSITION FOR RECHARGEABLE BATTERIES | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2015-02-12 | — | — | WO | claimed |
| EP-2705108-A1 | THERMALLY-ACTIVATED, HIGH-TEMPERATURE CEMENT SUSPENDING AGENT | Halliburton Energy Services, Inc. (US) | 2014-03-12 | — | — | EP | claimed |
| US-20130150483-A1 | Thermally-Activated, High-Temperature Cement Suspending Agent | HALLIBURTON ENERGY SERVICES, INC. (US) | 2013-06-13 | — | — | US | claimed |
| WO-2013062700-A1 | DELAYED, SWELLABLE PARTICLES FOR PREVENTION OF FLUID MIGRATION THROUGH DAMAGED CEMENT SHEATHS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2013-05-02 | — | — | WO | claimed |
| US-20130105161-A1 | Delayed, Swellable Particles for Prevention of Fluid Migration Through Damaged Cement Sheaths | HALLIBURTON ENERGY SERVICES, INC. (US) | 2013-05-02 | — | — | US | claimed |
| WO-2012150431-A1 | THERMALLY-ACTIVATED, HIGH-TEMPERATURE CEMENT SUSPENDING AGENT | HALLIBURTON ENERGY SERVICES, INC. (US) | 2012-11-08 | — | — | WO | claimed |
| US-20120279707-A1 | Thermally-Activated, High-Temperature Cement Suspending Agent | HALLIBURTON ENERGY SERVICES, INC. (US) | 2012-11-08 | — | — | US | claimed |